A Comparison of Hydromorphone-Bupivacaine and Fentanyl-Bupivacaine in Patient Controlled Epidural Analgesia after Thoracotomy

개흉술 후 경막외 통증자가조절을 설시한 환자에서 Hydromorphone-Bupivacaine과 Fentanyl-Bupivacaine 투여의 비교

  • Sim, Woo Seok (Department of Anesthesiology and Pain Medicine, Sungkyunkwan University School of Medicine) ;
  • Yeo, Jin Seok (Department of Anesthesiology and Pain Medicine, Sungkyunkwan University School of Medicine)
  • 심우석 (성균관대학교 의과대학 삼성서울병원 마취통증의학교실) ;
  • 여진석 (성균관대학교 의과대학 삼성서울병원 마취통증의학교실)
  • Received : 2005.09.20
  • Accepted : 2005.12.09
  • Published : 2005.12.10

Abstract

Background: Hydromorphone has an intermediate lipid solubility range that falls between morphine and fentanyl. Lipophilic activity during opioid epidural administration is important in relation to both the side effects and analgesic efficacy. The purpose of this study was to compare epidural hydromorphone and fentanyl when concomitantly infused with bupivacaine in patients undergoing a thoracotomy. Methods: Seventy-seven thoracotomy patients, with patient-controlled epidural analgesia (PCEA), were blindly allocated into two groups [group F (n = 34); 0.1% bupivacaine and fentanyl $5{\mu}g/ml$, group H (n = 34); 0.1% bupivacaine and hydromorphone $16{\mu}g/ml$)]. The basal PCEA rate and demand dose were 4 ml/hr and 3 ml, respectively. The visual analogue scale (VAS) for pain, and pruritus, sedation and nausea were measured at 6, 12 and 24 hours after the operation. Results: There were no significant differences in the VAS pain scores and the incidences of pruritus, nausea and sedation between the two groups. The total infused volume after 24 hours was lower in H compared to that of F group (P < 0.05). Conclusions: We conclude that epidural hydromorphone or fentanyl administration has a similar analgesic efficacy and shows similar incidences of side effects, when concomitantly infused with bupivacaine, in the management of acute pain following a thoracotomy.

Keywords

References

  1. Brodsky JB, Chaplan SR, Brose WG, Mark JB: Continuous epidural hydromorphone for postthoracotomy pain relief. Ann Thorac Surg 1990; 50: 888-93.
  2. Shulman M, Sandler AN, Bradley JW, Young PS, Brebnet J: Postthoracotomypain and pulmonary function following epidural and systemic morphine. Anesthesiolgy 1984; 61: 569-75.
  3. Fisher RL, Lubenow TR, Liceaga A, McCarthy RJ, Iankovich AD: Comparison of continuous epidural infusion of fentanyl-bupivacaine and morphine-bupivacaine in management of postopetative pain. Anesth Analg 1998; 67: 559-63.
  4. Saito Y, Uchida H, Kaneko M, Nakatani T, Kosaka Y: Comparison of continuous epidural infusion of morphine/bupivacaine with fentanyl/bupivacaine for postoperative pain relief. Acta Anaesthesiol Scand 1994; 38: 398-401. https://doi.org/10.1111/j.1399-6576.1994.tb03915.x
  5. Romer HC, Russell GN: A survey of the practice of thotacic epidural analgesia in rhe United Kingdom. Anaesthesia 1998; 53: 1016-22.
  6. Mahon SV, Berry PD, Jackson M, Russell GN, Pennefather SH: Thoracic epidural infusions for post-thoracotomy pain: a comparison of fentanyl-bupivacaine mixtures vs. fentanyl alone. Anaesthesia 1999; 54: 641-6.
  7. Mourisse J, Hasenbos MA, Gielen MJ, Moll JE, Cromheecke G]: Epidural bupivacaine, sufentanil or the combination for post-thoracotomy pain. Acta Anaesthesio! Scand 1992; 36: 70-4.
  8. Goodarzi M: Comparision of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery. Paediatr Anaesth 1999; 9: 419-22.
  9. Golembiewski J, Torrecer S, Katke]: The use of opioids in the postoperative setting: focus on morphine, hydromorphone, and fentanyl. J Perianesth Nurs 2005; 20: 141-3.
  10. Roy SD, Flynn Gl: Solubility and Related Physicochemical Properties of Narcotic Analgesics. Pharm Res 1988; 5: 580-6.
  11. Bromage PR, Camporesi E, Chestnut D: Epidural narcotics for postoperative analgesia. Anesth Analg 1980; 59: 473-80.
  12. Chaplan SR, Duncan SR, Brodsky JB, Brose WG: Morphine and hydromorphone epidural analgesia. Anesthesiolgy 1992; 77: 1090-4.
  13. Coombs DW, Colburn RW, DeLeo JA, Hoopes PJ, Twitchell BB: Comparative spinal neuropathology of hydromorphone and morphine after 9- and 30-day epidural administration in sheep. Anesth Analg 1994; 79: 674-81.
  14. Halpern SH, Arellano R, Preston R, Carstoniu J, O'Leary G, Roger S, er al: Epidural morphine vs hydromorphone in post-caesarean section patients. Can J Anaesth 1996; 43: 595-8.
  15. Tan CN, Guha A, Scawn ND, Pennefather SH, Russell GN: Optimal concentration of epidural fentanyl in bupivacaine 0.1% after thoracotomy. Br J Anaesrh 2004; 92: 670-4.
  16. Dunbar PJ, Chapman CR, Buckley FP, Gavrin JR: Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain 1996; 68: 265-70.
  17. Kim DH, Kwak SH, Yang SH, Jeong SW, Yoon MH, Jeong CY: A Comparison of Epidural Fentanyl-Bupivacaine and Intravenous Morphine Using Patient-Controlled Analgesia after Thoracic Surgery. Korean J Anesthesiol 1999; 36: 846-55.
  18. Chaney MA: Side effects of intrathecal and epidural opioids. Can J Anaesth 1995; 42: 891-903.
  19. Menigaux C, Guignard B, Fletcher D, Sessler DI, Levron J, Chauvin M: More epidural than intravenous sufentanil is required to provide comparable postoperative pain relief. Anesth Analg 2001; 93: 472-6.
  20. Ginosar Y, Riley ET, Angst MS: The site of action of epidural fentanyl in humans: the difference between infusion and bolus administration. Anesth Analg 2003; 97: 1428-38.
  21. Ginosar Y, Riley ET, Angst MS: The site of action of epidural fentanyl in humans: the difference between infusion and bolus administration. Anesth Analg 2003; 97: 1428-38.